Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2026-04-07 08:47:16 ET · period of report 2026-04-01 · accession 0001493152-26-015456 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-07 08:47 | 2026-04-01 | ABEO | Goldan Keith A. | Dir | A - Grant | $0.00 | +32.8K | 32.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-01 | A | A | 32,751 | $0.00 | 32,751 | D | — | — | (F1) All of the restricted stock will vest on April 1, 2027. |